Despite major advances in methodology and thousands of published studies every year,treatment outcomes in schizophrenia have not improved over the last fifty years. Moreover, we stilllack strategies for prevention and we do not yet understand how the interaction of genetic,developmental, and environmental factors contribute to the disorder. In this book, leadingresearchers consider conceptual and technical obstacles to progress in understanding schizophreniaand suggest novel strategies for advancing research and treatment.
Thecontributors address a wide range of critical issues: the construct of schizophrenia itself;etiology, risk, prediction, and prevention; different methods of modeling the disorder; andtreatment development and delivery. They identify crucial gaps in our knowledge and offer creativebut feasible suggestions. These strategies include viewing schizophrenia as a heterogeneous group ofconditions; adopting specific new approaches to prediction and early intervention; developing betterintegration of data across genetics, imaging, perception, cognition, phenomenology, and otherfields; and moving toward an evidence-based, personalized approach to treatment requiring rationalclinical decision-making to reduce functionaldisability.
ContributorsRobert Bittner, Robert W. Buchanan,Kristin S. Cadenhead, William T. Carpenter, Jr., Aiden Corvin, Daniel Durstewitz, Andre A. Fenton,Camilo de la Fuente-Sandoval, Jay A. Gingrich, Joshua A. Gordon, Chloe Gott, Peter B. Jones, Rene S.Kahn, Richard Keefe, Wolfgang Kelsch, James L. Kennedy, Matcheri S. Keshavan, Angus W. MacDonaldIII, Anil K. Malhotra, John McGrath, Andreas Meyer-Lindenberg, Kevin J. Mitchell, Bita Moghaddam,Vera A. Morgan, Craig Morgan, Kim T. Mueser, Karoly Nikolich, Patricio O'Donnell, Michael O'Donovan,William A. Phillips, Wulf Rossler, Louis Sass, Akira Sawa, Jeremy K. Seamans, Steven M. Silverstein,William Spaulding, Sharmili Sritharan, Heike Tost, Peter Uhlhaas, Aristotle Voineskos, MicheleWessa, Leanne M. Williams, Ashley Wilson, Til Wykes
Steven M. Silverstein is Director of the Division of Schizophrenia Research at University Behavioral HealthCare, Rutgers Biomedical and Health Services, Rutgers University.
外文書商品之書封，為出版社提供之樣本。實際出貨商品，以出版社所提供之現有版本為主。部份書籍，因出版社供應狀況特殊，匯率將依實際狀況做調整。
無庫存之商品，在您完成訂單程序之後，將以空運的方式為你下單調貨。為了縮短等待的時間，建議您將外文書與其他商品分開下單，以獲得最快的取貨速度，平均調貨時間為1~2個月。
為了保護您的權益，「三民網路書店」提供會員七日商品鑑賞期(收到商品為起始日)。
若要辦理退貨，請在商品鑑賞期內寄回，且商品必須是全新狀態與完整包裝(商品、附件、發票、隨貨贈品等)否則恕不接受退貨。
